AIDS VACCINE ADVOCACY COALITION INC

RESEARCH ENGAGEMENT AND PREPAREDNESS: RESEARCH PREPAREDNESS IS DESIGNED TO SHAPE THE R&D ENVIRONMENT THROUGH ADVOCACY FOR INVESTMENT, POLITICAL SUPPORT, AND GOOD PARTICIPATORY PRACTICE. AVAC TRACKS AND TRANSLATES BOTH COMMUNITY ADVOCACY AND COMPLEX SCIENCE TO MAKE THE SCIENCE ACCESSIBLE AND POSITION COMMUNITY PRIORITIES AT THE CENTER OF GLOBAL HEALTH. AVAC IMPROVED TRIAL DESIGN AND CONDUCT BY BRINGING TOGETHER RESEARCHERS, TRIAL SITE STAFF, CIVIL SOCIETY, POLICYMAKERS, TRIAL PARTICIPANTS, AND COMMUNITIES TO CENTER PERSPECTIVES OF AFFECTED COMMUNITIES IN RESEARCH. AVAC DEVELOPED MATERIALS AND DOCUMENTS RELATING TO THE PREVENTION OF HIV/AIDS; CONVENED MULTIPLE MEETINGS WITH STAKEHOLDERS SUCH AS RESEARCHERS AND CIVIL SOCIETY LEADERS TO DISCUSS RESEARCH FINDINGS; PROGRAM SERVICE ACCOMPLISHMENTS.

POLICY ADVOCACY: AVAC WORKS WITH PARTNERS AND POLICYMAKERS TO DEVELOP AND PURSUE NATIONAL, REGIONAL, AND INTERNATIONAL AGENDAS THAT ADVANCE HIV PREVENTION AND GLOBAL HEALTH EQUITY AND LAY A FOUNDATION FOR GLOBAL HEALTH SECURITY AGAINST FUTURE PANDEMICS. AVAC HELPS SHAPE GLOBAL HEALTH SPENDING AND PLANNING FOR HIV PREVENTION BY MOBILIZING TO ENSURE PROGRAMS, PRODUCTS AND POLICIES ARE EVIDENCE-BASED, INCLUSIVE AND EFFECTIVE. WITH A NETWORK OF PARTNERS, AVAC IDENTIFIES POLICY NEEDS AND DEVELOPS CAMPAIGNS TO ADVANCE HIV PREVENTION WITH A FOCUS ON ENSURING RICH, COMMUNITY-SUPPORTED ADVOCACY NETWORKS AND MAJOR AFRICA-LED INITATIVES TO CALL FOR CHOICE AND EQUITY IN HIV PREVENTION INVESTMENTS GLOBALLY; AND ISSUED SUBGRANTS TO MORE THAN 13 PARTNERS IN THE US AND AFRICA (CONTINUED ON SCHEDULE O)CONTINUED: UNDER THE HIV BIOMEDICAL PREVENTION RESEARCH PROJECT FUNDED BY USAID TO IDENTIFY AND MITIGATE OR ELIMINATE BARRIERS TO THE DEVELOPMENT OF AND ACCESS TO NEW HIV VACCINES AND OTHER PREVENTION OPTIONS; AND PROMOTE INCREASED RESOURCES FOR HIV VACCINE AND PREVENTION RESEARCH BY DONORS INCLUDING GOVERNMENT AGENCIES.